The UCL and Ludwig Institute for Cancer Research spinout has collected $125m from investors including existing shareholder Vives Louvain Technology Fund.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The WuXi-backed investment firm returned for a series B2 round that will support phase 1/2 trials for iTeos Therapeutics' oncology therapies.

Autoimmune disease drug developer Pandion Therapeutics closed a series B round co-led by Access Biotechnology and backed by Roche Venture Fund and SR One.

The enterprise communication platform developer has now raised more than $62m altogether, Dell Technologies Capital leading its latest round.

Intel Capital led a $14.1m round for the cancer diagnostics system provider, its parent company having already supplied it with artificial intelligence technology.

Born out of the Stanford Virtual Human Interaction Lab, Strivr uses virtual reality to train athletes and employees and has now collected $51m in funding altogether.

Prologis Ventures was among the investors that helped the virtual training system provider hike its overall funding to $51m.

AristaMD, developer of a remote diagnostics system, raised $18m in a round backed by CU Healthcare Innovation Fund.

AristaMD, developer of a remote diagnostics system, raised $18m in a round co-led by Cigna Ventures and MemorialCare Innovation Fund.